Suit settled
Smiths Medical has entered into a cross-licensing agreement with Medtronic MiniMed, terminating all pending litigation between the companies relating to the Deltec Cozmo insulin pump.

The
’s
announced yesterday that Smiths Medical has entered into a cross-licensing agreement with
.
The agreement terminates all pending litigation between the companies relating to the Deltec Cozmo insulin pump, and confirms that no changes are required to the design of the pump.
Minneapolis-based Medtronic’s lawsuit against Smiths Medical alleged that Smiths Medical wilfully infringed Medtronic patents related to its insulin pumps
Under the terms of the agreement Smiths will make an initial payment to Medtronic and will pay a royalty on future sales of the current model.
The costs of the settlement will be treated as an exceptional charge in Smiths Group's 2005 Accounts. Subject to audit, this charge is expected to be no more than £15 million.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Radio wave weapon knocks out drone swarms
Probably. A radio-controlled drone cannot be completely shielded to RF, else you´d lose the ability to control it. The fibre optical cable removes...